1.27
price up icon1.60%   0.02
 
loading
Precedente Chiudi:
$1.25
Aprire:
$1.25
Volume 24 ore:
9,099
Relative Volume:
0.25
Capitalizzazione di mercato:
$62.29M
Reddito:
-
Utile/perdita netta:
$-9.51M
Rapporto P/E:
-6.6842
EPS:
-0.19
Flusso di cassa netto:
$-10.96M
1 W Prestazione:
+0.00%
1M Prestazione:
-3.05%
6M Prestazione:
-13.01%
1 anno Prestazione:
-39.52%
Intervallo 1D:
Value
$1.25
$1.27
Intervallo di 1 settimana:
Value
$1.23
$1.29
Portata 52W:
Value
$1.13
$2.55

Medicinova Inc Stock (MNOV) Company Profile

Name
Nome
Medicinova Inc
Name
Telefono
858-373-1500
Name
Indirizzo
4275 EXECUTIVE SQUARE, LA JOLLA, CA
Name
Dipendente
6
Name
Cinguettio
@MedicinovaJapan
Name
Prossima data di guadagno
2025-08-15
Name
Ultimi documenti SEC
Name
MNOV's Discussions on Twitter

Confronta MNOV con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
MNOV
Medicinova Inc
1.27 61.31M 0 -9.51M -10.96M -0.19
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
391.64 101.35B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
456.00 58.66B 2.46B -319.09M -52.09M -2.47
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
562.27 59.43B 14.21B 4.46B 3.56B 39.68
Biotechnology icon
ARGX
Argen X Se Adr
737.56 44.01B 3.06B 1.28B 447.35M 21.30
Biotechnology icon
ONC
Beone Medicines Ltd Adr
340.70 36.56B 3.81B -644.79M -669.77M -6.24

Medicinova Inc Stock (MNOV) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2021-03-10 Iniziato Maxim Group Buy
2019-03-25 Ripresa B. Riley FBR Buy
2018-03-28 Iniziato B. Riley FBR, Inc. Buy
2017-04-18 Iniziato Credit Suisse Outperform
2013-01-04 Reiterato Ladenburg Thalmann Buy
2012-05-24 Downgrade MLV & Co Buy → Hold
2011-10-18 Reiterato MLV Capital Buy
2011-06-22 Iniziato Global Hunter Securities Buy
2010-05-12 Iniziato Wedbush Outperform
2008-11-12 Reiterato Ladenburg Thalmann Buy
2008-05-15 Iniziato Rodman & Renshaw Mkt Outperform
2007-07-09 Iniziato Punk, Ziegel & Co Buy
Mostra tutto

Medicinova Inc Borsa (MNOV) Ultime notizie

pulisher
Sep 30, 2025

Can a trend reversal in MediciNova Inc. lead to recoveryMarket Sentiment Summary & Breakout Confirmation Trade Signals - newser.com

Sep 30, 2025
pulisher
Sep 30, 2025

What drives MediciNova Inc stock priceAnalyst Downgrades & Small Budget Trading Ideas - earlytimes.in

Sep 30, 2025
pulisher
Sep 30, 2025

MediciNova Inc. recovery potential after sell offQuarterly Performance Summary & Reliable Volume Spike Trade Alerts - newser.com

Sep 30, 2025
pulisher
Sep 30, 2025

Long term hold vs stop loss in MediciNova Inc.2025 Technical Overview & Free Risk Controlled Daily Trade Plans - newser.com

Sep 30, 2025
pulisher
Sep 30, 2025

Why MediciNova Inc. stock is favored by top institutions2025 Year in Review & Reliable Volume Spike Trade Alerts - newser.com

Sep 30, 2025
pulisher
Sep 30, 2025

Will MediciNova Inc. stock benefit from sector rotationEarnings Recap Report & Daily Profit Focused Screening - newser.com

Sep 30, 2025
pulisher
Sep 30, 2025

What MACD signals say about MediciNova Inc.2025 Major Catalysts & Daily Stock Trend Reports - newser.com

Sep 30, 2025
pulisher
Sep 29, 2025

What does recent volatility data suggest for MediciNova Inc.July 2025 Spike Watch & High Return Trade Opportunity Guides - newser.com

Sep 29, 2025
pulisher
Sep 29, 2025

Custom strategy builders for tracking MediciNova Inc.Portfolio Value Report & AI Enhanced Trading Alerts - newser.com

Sep 29, 2025
pulisher
Sep 27, 2025

Is MediciNova Inc a good long term investmentSupport and Resistance Levels & Interactive Learning for Better Returns - Early Times

Sep 27, 2025
pulisher
Sep 24, 2025

StockNews.com Begins Coverage on MediciNova (NASDAQ:MNOV) - 富途牛牛

Sep 24, 2025
pulisher
Sep 23, 2025

MediciNova (NASDAQ:MNOV) Receives “Buy” Rating from D. Boral Capital - Defense World

Sep 23, 2025
pulisher
Sep 22, 2025

MediciNova completes patient enrollment in phase 2/3 ALS trial - Investing.com India

Sep 22, 2025
pulisher
Sep 22, 2025

MediciNova completes patient enrollment in phase 2/3 ALS trial By Investing.com - Investing.com South Africa

Sep 22, 2025
pulisher
Sep 22, 2025

MediciNova (MNOV) Maintains "Buy" Rating from D. Boral Capital | - GuruFocus

Sep 22, 2025
pulisher
Sep 22, 2025

MediciNova (MNOV) Completes Enrollment for Key ALS Treatment Tri - GuruFocus

Sep 22, 2025
pulisher
Sep 22, 2025

MediciNova Completes Patient Enrollment in Phase 2b/3 Trial of Ibudilast for Treatment of ALS - MarketScreener

Sep 22, 2025
pulisher
Sep 22, 2025

MediciNova Announces Completion of Patient Enrollment - GlobeNewswire

Sep 22, 2025
pulisher
Sep 22, 2025

MediciNova Announces Completion of Patient Enrollment in COMBAT- - GuruFocus

Sep 22, 2025
pulisher
Sep 22, 2025

234 ALS Patients Enrolled: MediciNova's Fast-Track Drug Trial Could Offer New Hope for Fatal Disease - Stock Titan

Sep 22, 2025
pulisher
Sep 22, 2025

MediciNova Announces Completion of Patient Enrollment in COMBAT-ALS Phase 2b/3 Clinical Trial of MN-166 (ibudilast) - Yahoo Finance

Sep 22, 2025
pulisher
Sep 21, 2025

Building trade automation scripts for MediciNova Inc.Weekly Volume Report & Community Shared Stock Ideas - newser.com

Sep 21, 2025
pulisher
Sep 20, 2025

Gains Report: What is the next catalyst for MediciNova IncProfit Target & High Return Trade Opportunity Guides - خودرو بانک

Sep 20, 2025

Medicinova Inc Azioni (MNOV) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$20.66
price down icon 2.36%
$84.81
price up icon 1.10%
$30.67
price up icon 4.57%
$98.62
price up icon 0.53%
$144.01
price up icon 1.67%
biotechnology ONC
$340.70
price up icon 2.36%
Capitalizzazione:     |  Volume (24 ore):